Ignite Creation Date:
2024-06-16 @ 11:52 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06456567
Status:
RECRUITING
Last Update Posted:
2024-06-13
First Post:
2024-06-07
Brief Title:
A Study of Telitacicept for the Treatment of Moderately to Severely Active Systemic Lupus Erythematosus REMESLE-2
Sponsor:
RemeGen Co Ltd
Organization:
RemeGen Co Ltd